650218
1-(4-氯苄基)哌嗪
98%
登录 查看公司和协议定价
选择尺寸
关于此项目
经验公式（希尔记法）:
C11H15ClN2
化学文摘社编号:
分子量:
210.70
MDL號碼:
分類程式碼代碼:
12352100
PubChem物質ID:
NACRES:
NA.22
化驗
98%
折射率
n20/D 1.5580 (lit.)
bp
104-106 °C/0.1 mmHg (lit.)
密度
1.140 g/mL at 25 °C (lit.)
SMILES 字串
Clc1ccc(CN2CCNCC2)cc1
InChI
1S/C11H15ClN2/c12-11-3-1-10(2-4-11)9-14-7-5-13-6-8-14/h1-4,13H,5-9H2
InChI 密鑰
GSJXJZOWHSTWOX-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
訊號詞
Danger
危險聲明
危險分類
Acute Tox. 4 Oral - Eye Dam. 1 - Skin Corr. 1B
儲存類別代碼
8A - Combustible corrosive hazardous materials
水污染物質分類（WGK）
WGK 3
閃點（°F）
>230.0 °F - closed cup
閃點（°C）
> 110 °C - closed cup
個人防護裝備
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
K Hashimoto et al.
Brain research, 590(1-2), 341-344 (1992-09-11)
The neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA) in rat brain was attenuated significantly by coadministration of several benzylpiperazines (p-nitrobenzylpiperazine, p-chlorobenzylpiperazine and 1-piperonylpiperazine), which were weak inhibitors for [3H]6-nitroquipazine binding to the 5-hydroxytryptamine (5-HT) transporter in rat brain. These results suggest that these
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持